Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CT imaging of pediatric patients with cystic fibrosis on ivacaftor therapy.

Lung - 1 Oct 2014

Hayes Don, Long Frederick R, McCoy Karen S, Sheikh Shahid I

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aminophenols
Share to Cystic Fibrosis
Share to Cystic Fibrosis Transmembrane Conductance Regulator
Share to Forced Expiratory Volume

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Quinolones

Share to Recovery of Function

Share to Tomography, X-Ray Computed

Share to Vital Capacity

Source

Identifiers

PMID: 25099273
DOI: 10.1007/s00408-014-9629-y

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CT imaging of pediatric patients with cystic fibrosis on ivacaftor therapy.PMID 25099273Read ↗

Ivacaftor for cystic fibrosis.Semantic proximity Read ↗

Lumacaftor/ivacaftor (Orkambi) for cystic fibrosis.Semantic proximity Read ↗

Real Life With Tezacaftor and Ivacaftor in Adult Patients With Cystic Fibrosis: Spanish Multicenter Study.Semantic proximity Read ↗

Clinical and functional course of patients with cystic fibrosis treated with lumacaftor/ivacaftor at a children's hospital. A case series.Semantic proximity Read ↗

Effects of Lumacaftor/Ivacaftor on Cystic Fibrosis Disease Progression in Children 2 through 5 Years of Age Homozygous for F508del-CFTR: A Phase 2 Placebo-controlled Clinical Trial.Semantic proximity Read ↗

Improvement in sinonasal quality-of-life indicators for pediatric patients with cystic fibrosis treated with elexacaftor-tezacaftor-ivacaftor.Semantic proximity Read ↗

Effects of Ivacaftor in Three Pediatric Siblings With Cystic Fibrosis Carrying the Mutations G551D And F508del.Semantic proximity Read ↗

Ivacaftor and sinonasal pathology in a cystic fibrosis patient with genotype delta F508/S1215NSemantic proximity Read ↗

Computed tomography correlates with improvement with ivacaftor in cystic fibrosis patients with G551D mutation.Semantic proximity Read ↗

Structural changes in lung morphology detected by MRI after modulating therapy with elexacaftor/tezacaftor/ivacaftor in adolescent and adult patients with cystic fibrosis.Semantic proximity Read ↗

Use of hyperpolarized helium-3 MRI to assess response to ivacaftor treatment in patients with cystic fibrosis.Semantic proximity Read ↗

Ivacaftor therapy in siblings with cystic fibrosis-the potential implications of Itraconazole in dosage and efficacy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.